- Presentations
- 6
- Markets
- 1
Retevmo is a brand of Selpercatinib marketed by Eli Lilly, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Selpercatinib
- Brand owner
- Eli Lilly
- Registered in
- United States
- Strengths and forms
- 40 mg capsule, 80 mg capsule, 120 mg tablet, 160 mg tablet, 40 mg tablet, 80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Retevmo 40 mg capsuleOral | Eli Lilly | US FDA | Available on request |
| Retevmo 80 mg capsuleOral | Eli Lilly | US FDA | Available on request |
| Retevmo 120 mg tabletOral | Eli Lilly | US FDA | Available on request |
| Retevmo 160 mg tabletOral | Eli Lilly | US FDA | Available on request |
| Retevmo 40 mg tabletOral | Eli Lilly | US FDA | Available on request |
| Retevmo 80 mg tabletOral | Eli Lilly | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Retevmo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.